APA (7th ed.) Citation

Schneider, M. A., Limani, P., Linecker, M., Kron, P., Petrosky, H., Pestalozzi, B. C., . . . Clavien, P. (2018). 101PFirst evidence of antitumor activity of ITPP, a novel hypoxia-modifier: Results of a phase Ib trial. Annals of Oncology, 29, N.PAG. https://doi.org/10.1093/annonc/mdy487.032

Chicago Style (17th ed.) Citation

Schneider, M A., et al. "101PFirst Evidence of Antitumor Activity of ITPP, a Novel Hypoxia-modifier: Results of a Phase Ib Trial." Annals of Oncology 29 (2018): N.PAG. https://doi.org/10.1093/annonc/mdy487.032.

MLA (9th ed.) Citation

Schneider, M A., et al. "101PFirst Evidence of Antitumor Activity of ITPP, a Novel Hypoxia-modifier: Results of a Phase Ib Trial." Annals of Oncology, vol. 29, 2018, p. N.PAG, https://doi.org/10.1093/annonc/mdy487.032.